Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3

被引：75

作者：

Boyd, Scott ^{[1
]}

Brookfield, Joanna L. ^{[2
]}

Critchlow, Susan E. ^{[1
]}

Cumming, Iain A. ^{[2
]}

Curtis, Nicola J. ^{[1
]}

Debreczeni, Judit ^{[1
]}

Degorce, Sebastien L. ^{[1
]}

Donald, Craig ^{[1
]}

Evans, Nicola J. ^{[3
]}

Groombridge, Sam ^{[1
]}

Hopcroft, Philip ^{[1
]}

Jones, Neil P. ^{[3
]}

Kettle, Jason G. ^{[1
]}

Lamont, Scott ^{[1
]}

Lewis, Hilary J. ^{[1
]}

MacFaull, Philip ^{[1
]}

McLoughlin, Sheila B. ^{[2
]}

Rigoreau, Laurent J. M. ^{[2
]}

Smith, James M. ^{[2
]}

St-Gallay, Steve ^{[1
]}

Stock, Julie K. ^{[3
]}

Turnbull, Andrew P. ^{[3
]}

Wheatley, Edward R. ^{[3
]}

Winter, Jon ^{[1
]}

Wingfield, Jonathan ^{[1
]}

机构：

[1] AstraZeneca, Oncol Innovat Med Unit, Macclesfield SK10 4TG, Cheshire, England

[2] CRT Discovery Labs, Cambridge CB22 3AT, England

[3] UCL, Wolfson Inst Biomed Res, CRT Discovery Labs, London WC1E 6BT, England

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 08期

关键词：

KEY GLYCOLYTIC ENZYME; 6-PHOSPHOFRUCTO-2-KINASE PFKFB3; CANCER; PHOSPHOFRUCTOKINASE; EXPRESSION; FAMILY;

D O I：

10.1021/acs.jmedchem.5b00352

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A weak screening hit with suboptimal physicochemical properties was optimized against PFKFB3 kinase using critical structure-guided insights. The resulting compounds demonstrated high selectivity over related PFKFB isoforms and modulation of the target in a cellular context. A selected example demonstrated exposure in animals following oral dosing. Examples from this series may serve as useful probes to understand the emerging biology of this metabolic target.

引用

页码：3611 / 3625

页数：15

共 50 条

[21] Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine
Waldschmidt, Helen V.
Homan, Kristoff T.
Cato, Marilyn C.
Cruz-Rodriguez, Osvaldo
Cannavo, Alessandro
Wilson, Michael W.
Song, Jianliang
Cheung, Joseph Y.
Koch, Walter J.
Tesmer, John J. G.
Larsen, Scott D.
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (07) : 3052 - 3069
[22] Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (ABI) as ATR Inhibitors
Barsanti, Paul A.
Pan, Yue
Lu, Yipin
Jain, Rama
Cox, Matthew
Aversa, Robert J.
Dillon, Michael P.
Ening, Robert
Hu, Cheng
Jin, Xianming
Knapp, Mark
Lan, Jiong
Ramurthy, Savithri
Rudewicz, Patrick
Setti, Lina
Subramanian, Sharadha
Mathur, Michelle
Taricani, Lorena
Thomas, George
Xiao, Linda
Yue, Qin
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (01): : 42 - 46
[23] Structure-Based Design of 2-Aminopyridine Oxazolidinones as Potent and Selective Tankyrase Inhibitors
Huang, Hongbing
Guzman-Perez, Angel
Acquaviva, Lisa
Berry, Virginia
Bregman, Howard
Dovey, Jennifer
Gunaydin, Hakan
Huang, Xin
Huang, Liyue
Saffran, Doug
Serafino, Randy
Schneider, Steve
Wilson, Cindy
DiMauro, Erin F.
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (12): : 1218 - 1223
[24] Structure-based development of potent and selective type-Ⅱ kinase inhibitors of RIPK1
Ying Qin
Dekang Li
Chunting Qi
Huaijiang Xiang
Huyan Meng
Jingli Liu
Shaoqing Zhou
Xinyu Gong
Ying Li
Guifang Xu
Rui Zu
Hang Xie
Yechun Xu
Gang Xu
Zheng Zhang
Shi Chen
Lifeng Pan
Ying Li
Li Tan
Acta Pharmaceutica Sinica B, 2024, 14 (01) : 319 - 334
[25] Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors
Read, M
Harrison, RJ
Romagnoli, B
Tanious, FA
Gowan, SH
Reszka, AP
Wilson, WD
Kelland, LR
Neidle, S
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (09) : 4844 - 4849
[26] Structure-based design of highly potent and selective Cdk4 inhibitors.
Honma, T
Hayashi, K
Yoshizumi, T
Ikeura, C
Ikuta, M
Suzuki-Takahashi, I
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U437 - U438
[27] Structure-Based Development of Small Molecule PFKFB3 Inhibitors: A Framework for Potential Cancer Therapeutic Agents Targeting the Warburg Effect
Seo, Minsuh
Kim, Jeong-Do
Neau, David
Sehgal, Inder
Lee, Yong-Hwan
PLOS ONE, 2011, 6 (09):
[28] Structure-based design of thienobenzoxepin inhibitors of PI3-kinase
Staben, Steven T.
Siu, Michael
Goldsmith, Richard
Olivero, Alan G.
Do, Steven
Burdick, Daniel J.
Heffron, Timothy P.
Dotson, Jenna
Sutherlin, Daniel P.
Zhu, Bing-Yan
Tsui, Vickie
Le, Hoa
Lee, Leslie
Lesnick, John
Lewis, Cristina
Murray, Jeremy M.
Nonomiya, Jim
Pang, Jodie
Prior, Wei Wei
Salphati, Laurent
Rouge, Lionel
Sampath, Deepak
Sideris, Steve
Wiesmann, Christian
Wu, Ping
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (13) : 4054 - 4058
[29] Structure-Based Design of a Novel Series of Potent, Selective Inhibitors of the Class I Phosphatidylinositol 3-Kinases
Smith, Adrian L.
D'Angelo, Noel D.
Bo, Yurain Y.
Booker, Shon K.
Cee, Victor J.
Herberich, Brad
Hong, Fang-Tsao
Jackson, Claire L. M.
Lanman, Brian A.
Liu, Longbin
Nishimura, Nobuko
Pettus, Liping H.
Reed, Anthony B.
Tadesse, Seifu
Tamayo, Nuria A.
Wurz, Ryan P.
Yang, Kevin
Andrews, Kristin L.
Whittington, Douglas A.
McCarter, John D.
Miguel, Tisha San
Zalameda, Leeanne
Jiang, Jian
Subramanian, Raju
Mullady, Erin L.
Caenepeel, Sean
Freeman, Daniel J.
Wang, Ling
Zhang, Nancy
Wu, Tian
Hughes, Paul E.
Norman, Mark H.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5188 - 5219
[30] Structure-based approaches in the design of GSK-3 selective inhibitors
Patel, Dhilon S.
Dessalew, Nigus
Lqbal, Pansy
Bharatam, Prasad V.
CURRENT PROTEIN & PEPTIDE SCIENCE, 2007, 8 (04) : 352 - 364

← 1 2 3 4 5 →